• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾功能损害的高级别移行细胞癌切除术后感染新型冠状病毒的风险。

Risk of Covid-19 infection after resection of high grade transitional cell carcinoma with renal impairment.

作者信息

Murshidi Mujalli Mhailan, Ihmeidan Mohammad Khaled, Murshidi Muayyad Mujalli, Murshidi Rand Mujalli Sheikh Moh'd, Murshidi Raghad Mujalli

机构信息

Department of Special Surgery/Division of Urology, The University of Jordan, School of Medicine, Queen Rania Street, Amman 11942, Jordan.

Department of Special Surgery/Division of Urology, The University of Jordan, School of Medicine, Queen Rania Street, Amman 11942, Jordan.

出版信息

Int J Surg Case Rep. 2021 May;82:105924. doi: 10.1016/j.ijscr.2021.105924. Epub 2021 Apr 27.

DOI:10.1016/j.ijscr.2021.105924
PMID:33936935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8078049/
Abstract

INTRODUCTION AND IMPORTANCE

Covid-19 pandemic has had huge impact on health care system and put the health care system under strain, so efforts made to minimize the elective surgeries however some surgeries especially those for high risk malignant tumors cannot be postponed.The aim of this case report is to highlight the importance of screening cancer patients and those with co-morbidities such as renal impairment for Covid-19 and encouraging them to get vaccinated before undergoing elective surgeries.

CASE PRESENTATION

We report a case of an 80 year old male patient with renal impairment who developed Covid-19 infection after transurethral resection of high grade transitional cell carcinoma of urinary bladder.

CLINICAL DISCUSSION

Although intra-hospital contagion of Covid-19 is not rare, increased risk of acquiring Covid-19 among cancer patient particularly if they have co-morbidities like renal impairment should be kept in mind and strict protective measures for Covid-19 for those patients should be done before, during and after the procedure.

CONCLUSION

We theorized that patients with high grade transitional cell carcinoma of urinary bladder should be screened for Covid-19 and get vaccinated before the procedure.

摘要

引言与重要性

新冠疫情对医疗系统产生了巨大影响,使医疗系统不堪重负,因此人们努力减少择期手术,但某些手术,尤其是那些针对高危恶性肿瘤的手术无法推迟。本病例报告的目的是强调对癌症患者以及患有合并症(如肾功能损害)的患者进行新冠病毒筛查的重要性,并鼓励他们在接受择期手术前接种疫苗。

病例介绍

我们报告一例80岁男性肾功能损害患者,在经尿道膀胱高级别移行细胞癌切除术后感染了新冠病毒。

临床讨论

虽然新冠病毒在医院内传播并不罕见,但应牢记癌症患者,尤其是那些患有肾功能损害等合并症的患者感染新冠病毒的风险增加,并且在手术前、手术中和手术后应对这些患者采取严格的新冠病毒防护措施。

结论

我们推测,膀胱高级别移行细胞癌患者应在手术前进行新冠病毒筛查并接种疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/8113852/bf06a49d152f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/8113852/583aaa1e62ad/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/8113852/7880d93a66bb/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/8113852/bf06a49d152f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/8113852/583aaa1e62ad/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/8113852/7880d93a66bb/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/8113852/bf06a49d152f/gr3.jpg

相似文献

1
Risk of Covid-19 infection after resection of high grade transitional cell carcinoma with renal impairment.肾功能损害的高级别移行细胞癌切除术后感染新型冠状病毒的风险。
Int J Surg Case Rep. 2021 May;82:105924. doi: 10.1016/j.ijscr.2021.105924. Epub 2021 Apr 27.
2
[A case of asynchronous renal cell carcinoma and urothelial cancer of the urinary bladder and left ureter].[一例膀胱及左输尿管尿路上皮癌合并异步性肾细胞癌的病例]
Hinyokika Kiyo. 1993 Oct;39(10):927-30.
3
Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.再次经尿道膀胱肿瘤切除术(re-cTURBT)作为pT1期高级别(HG)疾病复发和进展的风险指标是否有用?一项单中心经验。
Arch Ital Urol Androl. 2017 Dec 31;89(4):272-276. doi: 10.4081/aiua.2017.4.272.
4
NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).1-氨基-2,4-二溴蒽醌(CAS编号:81-49-2)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学与致癌性研究(饲料喂养研究)
Natl Toxicol Program Tech Rep Ser. 1996 Aug;383:1-370.
5
Conservative management of low risk superficial bladder tumors.低风险浅表性膀胱肿瘤的保守治疗
J Urol. 2008 Jan;179(1):87-90; discussion 90. doi: 10.1016/j.juro.2007.08.171. Epub 2007 Nov 12.
6
Different treatment strategies for end stage renal disease in patients with transitional cell carcinoma.移行细胞癌患者终末期肾病的不同治疗策略。
J Urol. 2004 Jan;171(1):126-9. doi: 10.1097/01.ju.0000101758.41635.28.
7
Primary osteosarcoma of the urinary bladder treated with external radiotherapy in a patient with a history of transitional cell carcinoma: a case report.一名有移行细胞癌病史的患者接受体外放疗治疗的膀胱原发性骨肉瘤:病例报告
J Med Case Rep. 2010 Feb 24;4:70. doi: 10.1186/1752-1947-4-70.
8
Simultaneous renal cell carcinoma of the kidney and transitional cell carcinoma of the bladder.同时发生的肾细胞癌和膀胱移行细胞癌。
Can J Urol. 2002 Jun;9(3):1565-7.
9
Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?COVID-19 大流行期间肾移植受者中非黑色素瘤皮肤癌的诊断延迟:口罩背后隐藏着什么?
Acta Dermatovenerol Croat. 2021 Jul;29(2):111-113.
10
The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer.膀胱移行细胞癌患者经尿道膀胱肿瘤切除术后上尿路细胞学检查的价值。
J Urol. 1999 Jan;161(1):77-9; discussion 79-80.

本文引用的文献

1
The immuno-oncological challenge of COVID-19.COVID-19 的免疫肿瘤学挑战。
Nat Cancer. 2020 Oct;1(10):946-964. doi: 10.1038/s43018-020-00122-3. Epub 2020 Oct 2.
2
Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients.新型冠状病毒肺炎患者肾脏损害的发生率及危险因素:一项 10180 例患者的荟萃分析。
PLoS One. 2020 Nov 16;15(11):e0241953. doi: 10.1371/journal.pone.0241953. eCollection 2020.
3
The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines.
SCARE 2020 指南:更新共识手术病例报告(SCARE)指南。
Int J Surg. 2020 Dec;84:226-230. doi: 10.1016/j.ijsu.2020.10.034. Epub 2020 Nov 9.
4
Urologic oncology practice during COVID-19 pandemic: A systematic review on what can be deferrable vs. nondeferrable.COVID-19 大流行期间的泌尿肿瘤学实践:关于可推迟与不可推迟的系统评价。
Urol Oncol. 2020 Oct;38(10):783-792. doi: 10.1016/j.urolonc.2020.06.028. Epub 2020 Jun 26.
5
Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic.COVID-19 大流行期间泌尿外科手术的分诊考虑。
Eur Urol. 2020 Jun;77(6):663-666. doi: 10.1016/j.eururo.2020.03.027. Epub 2020 Apr 9.
6
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
7
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎(SARS-CoV-2)感染的癌症患者:一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
8
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
9
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
10
Management of high-risk non-muscle invasive bladder cancer.高危非肌层浸润性膀胱癌的管理
Minerva Urol Nefrol. 2012 Dec;64(4):255-60.